FRIST THOMAS F III

SEC source: 0001140361-26-018352 · form4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,858

F1 · kind: Represents shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer") underlying 509 restricted share units attributable to an annual director equity award and 532 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2027 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested Shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001140361-26-004684 · form4.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Frisco Holding II

Disclosed balance after: 36,557,141

F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

F2 · ownership.nature: Frisco holds 36,557,141 Shares. Frisco is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to exercise voting and investment control over the Shares held by Frisco, but disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein, which may be deemed to include indirect interests in Shares through ownership of Frisco partnership units to the extent of: 1,172 Shares by the Reporting Person; and 11,868,140 Shares by trusts for the benefit of the Reporting Person's children of which the Reporting Person or his spouse is trustee.

SEC source: 0001140361-26-004684 · form4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · By Frisco Holding II

Disclosed balance after: 0

F1 · kind: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

F1 · price: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

F1 · ownership.nature: On February 6, 2026, Frisco Holding II ("Frisco") disposed of 36,629,188 shares of Common Stock, par value $0.01 per share ("Shares"), of HCA Healthcare, Inc. (the "Issuer"), in exchange for 36,557,141 Shares newly issued by the Issuer to Frisco, in each case, in a transaction exempt from the registration requirements of the Securities Act of 1933 and from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 thereunder. These transactions, together with the conversion of Frisco to an entity taxable as a partnership for U.S. federal income tax purposes, constituted a reorganization for purposes of Section 368(a) of the Internal Revenue Code of 1986, as amended.

SEC source: 0001140361-25-016961 · form4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,817

F1 · kind: Represents common stock of HCA Healthcare, Inc. underlying 645 restricted share units attributable to an annual director equity award and 675 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001223892-24-000003 · wk-form4_1721853868.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,218

F1 · shares: On July 22, 2024, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-24-005455 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,497

F1 · kind: Represents common stock underlying 610 restricted share units attributable to an annual director equity award and 674 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2025 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001223892-23-000004 · wf-form4_169032403089916.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,810

F1 · shares: On July 24, 2023, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-23-025702 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,213

F1 · kind: Represents common stock underlying 663 restricted share units attributable to an annual director equity award and 733 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2024 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001223892-22-000007 · wf-form4_165895457205978.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,631

F1 · shares: On July 25, 2022, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-22-025855 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,817

F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 997 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001223892-22-000005 · wf-form4_165411646697069.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 95

F1 · shares: These shares were acquired by a managed partnership account, of which three trusts for the benefit of the Reporting Person's children collectively have a one-third interest. The Reporting Person serves as trustee for these three trusts.

SEC source: 0001223892-21-000003 · wf-form4_162690472047855.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,254

F1 · shares: On July 19, 2021, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-21-029398 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,918

F1 · kind: Represents common stock underlying 881 restricted share units attributable to an annual director equity award and 1,057 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2022 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-21-010854 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 9,507.583

F1 · ownership.nature: The Reporting Person directly owns 9,507.58295 units of Hercules Holding II ("Hercules") and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F2 · ownership.nature: Hercules holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

SEC source: 0001223892-20-000005 · wf-form4_159545109175038.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,161

F1 · shares: On July 20, 2020, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-20-027347 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,980

F1 · kind: Represents common stock underlying 1,668 restricted share units which shall vest on the sooner of the date of the 2021 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-20-009703 · doc5.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Thomas F. Frist III 2019 Annuity Trust I

Disclosed balance after: 843,932.4239

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person received gifts of 13,593.168989 and 315.234983 units of Hercules on May 21, 2019 and August 20, 2019, respectively, which were subsequently transferred to the Thomas F. Frist III 2019 Annuity Trust I, of which he serves as trustee. Following receipt of these gifts, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001223892-19-000002 · wf-form4_156400477320025.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,958

F1 · shares: On July 22, 2019, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-20-009703 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Thomas F. Frist III 2019 Annuity Trust I

Disclosed balance after: 843,617.1889

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person received gifts of 13,593.168989 and 315.234983 units of Hercules on May 21, 2019 and August 20, 2019, respectively, which were subsequently transferred to the Thomas F. Frist III 2019 Annuity Trust I, of which he serves as trustee. Following receipt of these gifts, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-19-027432 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,312

F1 · kind: Represents common stock underlying 1,410 restricted share units which shall vest on the sooner of the date of the 2020 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001223892-18-000004 · wf-form4_153255347220399.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,801

F1 · shares: On July 24, 2018, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-18-028169 · doc4.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,902

F3 · shares: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the 2019 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-18-028169 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II

Disclosed balance after: 22,168.0001

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person directly owns 22,168.0001 units of Hercules and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc. by virtue of his ownership in Hercules.

SEC source: 0001223892-17-000008 · wf-form4_150118763419404.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,117

F1 · shares: On July 25, 2017, Reporting Person was awarded restricted stock units (RSUs). Each RSU represents a contingent right to receive one (1) share of VeriSign, Inc. common stock once vested. The grant vests 100% on the date of grant, subject to applicable taxes upon delivery.

SEC source: 0001209191-18-010025 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Thomas F. Frist III 2017 Annuity Trust I

Disclosed balance after: 1,088,856.0364

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person received a gift of 9,366.66 units of Hercules on May 22, 2017, which were subsequently transferred to The Thomas F. Frist III 2017 Annuity Trust I, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

SEC source: 0001209191-17-030356 · doc4.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,112

F3 · kind: Represents common stock underlying 2,112 restricted share units which shall vest on the sooner of the date of the 2018 annual shareholders' meeting of HCA Holdings, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Holdings, Inc.

SEC source: 0001225208-17-008883 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Key Executive Stock Deferral Plan

Disclosed balance after: 4,717.4532

F1 · shares: Additional stock units acquired upon deemed reinvestment of dividend equivalents credited under the applicable plan.

SEC source: 0001209191-17-030356 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by Trusts for Children

Disclosed balance after: 2,348,330.3574

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F2 · ownership.nature: The Reporting Person may be deemed to be the beneficial owner of the aggregate (i) 28,489.62 units of Hercules held by certain trusts for the benefit of the Reporting Person's children, each of which his sister serves as trustee, and (ii) 2,348,330.3574 units of Hercules held by certain trusts for the benefit of the Reporting Person's children, each of which his wife serves as trustee, and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.

SEC source: 0001225208-17-002137 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Key Executive Stock Deferral Plan

Disclosed balance after: 4,697.8183

F1 · shares: Dividend equivalent rights.

SEC source: 0001225208-16-040939 · doc4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Key Executive Stock Deferral Plan

Disclosed balance after: 4,680.2932

F1 · shares: Dividend equivalent rights.

SEC source: 0001209191-17-010692 · doc5.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Held indirectly through Hercules Holding II by The Thomas F. Frist III 2016 Annuity Trust I

Disclosed balance after: 1,745,571.4876

F1 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of the common stock of HCA Holdings, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist, Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Holdings, Inc. held by Hercules. However, the Reporting Person disclaims membership in any such group and disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. On September 23, 2016, Hercules Holding II, LLC, a Delaware limited liability company, was converted into Hercules Holding II, a Delaware general partnership.

F2 · ownership.nature: The Reporting Person received a gift of 24,731 units of Hercules on February 17, 2016, which were subsequently transferred to The Thomas F. Frist III 2016 Annuity Trust I, of which he serves as trustee. Following receipt of this gift, the Reporting Person may be deemed the beneficial owner of the units of Hercules held by this trust and therefore may be deemed to own indirectly the same number of shares of common stock of HCA Holdings, Inc.